Abstract Body

People with HIV (PWH) taking antiretroviral therapy (ART) have persistent cognitive impairment. The prevalence of cognitive impairment is higher in women with HIV compared to men with HIV, possibly due to sex differences in immune function. Here we report sex differences in cerebrospinal fluid (CSF) immune markers in relation to cognitive performance in the context of ART mediated viral suppression.

A subset of 83 PWH on ART (52% women; mean age=37.6 years) from the Rakai community cohort study Cohort and Rakai Health Sciences Program supported clinics in rural Uganda completed a neuropsychological (NP) assessment and a lumbar puncture. CSF was used to measure 16 cytokines/chemokines via multiplex profiling with Luminex Platform (Human 17-Plex Panel, Bio-Rad, Hercules, CA). Individual NP test z-scores were generated based on local normative data. A series of least absolute shrinkage and selection operator (lasso) regressions examined associations between CSF inflammatory markers and NP outcomes after adjusting for alcohol use and pre-ART log viral load.

In the absence of sex-differences in overall levels of CSF inflammatory markers (P>0.05, Figure 1a) the number and patterns of cognitive correlates of neuroinflammation differed by sex (Figure 1 b, c) Among men, eleven of the sixteen markers were associated with NP outcomes with MIP-1?, IL-7, and IL-12p70 correlating with most outcomes. Conversely, women had fewer associations between inflammatory markers and NP outcomes, where each marker only correlated with one or two outcomes. Sociodemographic and clinical factors were similar by sex.

Women with HIV have previously been shown to be more vulnerable to immune dysfunction and impaired cognition compared to men, including exhibiting higher CSF HIV viral loads. Here we find that men have a larger number of associations between CSF biomarkers and cognitive outcomes than women in the context of similar levels of CSF biomarkers of inflammation in men and women. Some of these patterns indicate a positive relationship between immune regulation and cognition, particularly in men. Our findings provide initial evidence that neuroinflammation may contribute to sex differences in cognition in PWH. Further investigation in larger cohorts and longitudinal studies may lead to delineation of sex-specific mechanisms of cognitive dysfunction in HIV and, possibly impact sex-specific screenings and management to limit the neurological complications of HIV in the ART era.